Cargando…
Validation of an NGS mutation detection panel for melanoma
BACKGROUND: Knowledge of the genotype of melanoma is important to guide patient management. Identification of mutations in BRAF and c-KIT lead directly to targeted treatment, but it is also helpful to know if there are driver oncogene mutations in NRAS, GNAQ or GNA11 as these patients may benefit fr...
Autores principales: | Reiman, Anne, Kikuchi, Hugh, Scocchia, Daniela, Smith, Peter, Tsang, Yee Wah, Snead, David, Cree, Ian A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5322598/ https://www.ncbi.nlm.nih.gov/pubmed/28228113 http://dx.doi.org/10.1186/s12885-017-3149-0 |
Ejemplares similares
-
Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America
por: Salvo, Mauricio, et al.
Publicado: (2021) -
Key considerations for comprehensive validation of an RNA fusion NGS panel
por: Barua, Subit, et al.
Publicado: (2020) -
Identification of Novel Mutations by Targeted NGS Panel in Patients with Hyperferritinemia
por: Ravasi, Giulia, et al.
Publicado: (2021) -
Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
por: Aguilera-Diaz, Almudena, et al.
Publicado: (2020) -
Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
por: Cao, Wei, et al.
Publicado: (2019)